The Current Ratio as of November 2024 (TTM) for Exicure, Inc. (XCUR) is 0.61

According to Exicure, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 0.61. This represents a change of -27.72% compared to the average of 0.84 of the last 4 quarters.

Exicure, Inc. (XCUR) Historical Current Ratio (quarterly & annually)

How has XCUR Current Ratio performed in the past?

The mean historical Current Ratio of Exicure, Inc. over the last ten years is 6.21. The current 0.61 Current Ratio has changed 876.33% with respect to the historical average. Over the past ten years (40 quarters), XCUR's Current Ratio was at its highest in in the December 2018 quarter at 13.54. The Current Ratio was at its lowest in in the March 2016 quarter at 0.

Exicure, Inc. (XCUR) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Exicure, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Exicure, Inc. (XCUR) Average Current Ratio

How has XCUR Current Ratio performed in the past?

The current Current Ratio of Exicure, Inc. (XCUR) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Exicure, Inc. (XCUR) Current Ratio vs. Peers

How is XCUR’s Current Ratio compared to its peers?

Exicure, Inc.’s Current Ratio is less than Ikena Oncology, Inc. (18.22), greater than Enochian Biosciences, Inc. (0.07), less than Eliem Therapeutics, Inc. (60.41), greater than HCW Biologics Inc. (0.10), greater than ZIVO Bioscience, Inc. (0.17), less than RenovoRx, Inc. (4.39), less than Tempest Therapeutics, Inc. (2.17), greater than Catalyst Biosciences, Inc. (0), less than scPharmaceuticals Inc. (4.84), less than Milestone Pharmaceuticals Inc. (19.13), less than Oncolytics Biotech Inc. (4.99), less than Seres Therapeutics, Inc. (1.38), less than aTyr Pharma, Inc. (6.07), less than Lumos Pharma, Inc. (4.23), less than Marker Therapeutics, Inc. (5.92), less than Protagenic Therapeutics, Inc. (2.03), less than PMV Pharmaceuticals, Inc. (19.22), less than Imunon, Inc. (1.51), less than Cyclacel Pharmaceuticals, Inc. (1.07), less than Histogen Inc. (4.05), less than DiaMedica Therapeutics Inc. (17.82),

Build a custom stock screener for Exicure, Inc. (XCUR) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Exicure, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Exicure, Inc. (XCUR) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Exicure, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.